When is arthritis reactive?

Postgraduate Medical Journal

Volumn 82, Issue 969, 2006, Pages 446-453

  Hamdulay, S S ^a   Glynne, S J ^a   Keat, A ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZITHROMYCIN; CIPROFLOXACIN; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DOXYCYCLINE; HLA B27 ANTIGEN; LEFLUNOMIDE; LYMECYCLINE; METHOTREXATE; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RIFAMPICIN; SALAZOSULFAPYRIDINE;

CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; EYE DISEASE; GASTROINTESTINAL DISEASE; GENETIC SUSCEPTIBILITY; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUSCULOSKELETAL DISEASE; NAIL DISEASE; PHYSIOTHERAPY; PREVALENCE; REACTIVE ARTHRITIS; REVIEW; SKIN DISEASE; SPONDYLOARTHROPATHY; UROGENITAL TRACT DISEASE;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, REACTIVE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MEDICAL HISTORY TAKING; PHYSICAL EXAMINATION; PHYSICAL THERAPY MODALITIES; SPONDYLARTHROPATHIES;

EID: 33746047102     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2005.044057     Document Type: Review

References (88)

1. Ahvonen P, Sievers K, Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand 1969;15:232-53.
2. Bauer W, Engleman EP. A syndrome of unknown etiology characterized by urethritis, conjunctivitis, and arthritis (so-called Reiter's disease). Trans Assoc Am Physicians 1942;57:307-13.
3. Willkens RF, Arnett FC, Bitter T, et al. Reiter's syndrome. Evaluation of preliminary criteria for definite disease. Arthritis Rheum 1981;24:844-9.
4. Olhagen B. Urogenital syndromes and spondarthritis. Br J Rheumatol 1983;22(suppl 2):33-40.
5. Keat AC, Maini RN, Nkwazi GC, et al. Role of Chlamydia trachomatis and HLA-B27 in sexually acquired reactive arthritis. BMJ 1978;i:605-7.
6. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Diseases in the Young of the American Heart Association. Guidelines for the diagnosis of rheumatic fever. Jones criteria, 1992 update. JAMA 1992;268:2069-73.
7. Dougados M, van der Linden S, Juhlin R, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;341:1218-26.
8. Amor B, Dougados M, Mijijawa M. Criteres de classification des spondylarthropothies. Revue du Rhumatisme 1990;57:85-9.
9. Ziedler H, Mau W, Khan MA. Undifferentated spondylarthropathies. Rheum Clin North Am 1992;18:187-202.
10. Reiter H. Ueber eine bisher unerkannte Spirochateninfektion (Spirochaetosis Arthritica). Dtsch Med Wochenschr 1916;42:1535-6.
11. Brodie BC. Pathological and surgical observations on diseases of the joints. London: Longman, 1818:51-63.
12. Woodward JJ. The medical and surgical history of the War of the Rebellion. Part III. Vol 1. Washington, DC: Government Printing Office, 1888:407.
13. Paronen I. Reiter's disease; a study of 344 cases observed in Finland. Acta Med Scand Suppl 1948;212:1-112.
14. Noer HR. JAMA 1966;198:693-8.
15. Aho K, Ahvonen P, Lassus A, et al. HLA-B27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease. Arthritis Rheum 1974;17:521-6.
16. Isomaki H, Raunio J, von Essen R, et al. Incidence of inflammatory rheumatic diseases in Finland. Scand J Rheumatol 1978;7:188-92.
17. Hannu T, Kauppi M, Tuomala M, et al. Reactive arthritis following an outbreak of Campylobacter jejuni infection. J Rheumatol 2004;31:528-30.
18. Soderelin MK, Borjesson O, Kautiainen H, et al. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 2002;61:911-15.
19. Urfer E, Rossier P, Mean F, et al. Outbreak of Salmonella braenderup gastroenteritis due to contaminated meat pies: clinical and molecular epidemiology. Clin Microbiol Infect 2000;6:536-42.
20. Taylor-Robinson D, Keat A. How can a causal role for small bacteria in chronic inflammatory arthritides be established or refuted? Ann Rheum Dis 2001;60:177-84.
21. Bollet AJ. A report of reactive arthritis following dysentery in 1743. Arthritis Rheum 1981;24:860.
22. Bas S, Griffais R, Kvien T, et al. Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum 1995;38:1005-13.
23. Grantors K, Merilahti-Palo R, Luukkainen R, et al. Persistence of Yersinia antigens inperipheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum 1998;41:855-62.
24. Kuipers JG, Jurgens-Saathoff B, Bialowons A, et al. Detection of Chlamydia trachomatis in peripheral blood leukocytes of reactive arthritis patients by polymerase chain reaction. Arthritis Rheum 1998;41:1894-5.
25. Keat AC, Thomas BJ, Taylor-Robinson D, et al. Chlamydia trachomatis infection in sexually acquired reactive arthritis. Ann Rheum Dis 1980;39:431-7.
26. Mackie SL, Keat A. Poststreptococcal reactive arthritis: what is it and how do we know? Rheumatology (Oxf) 2004;43:949-54.
27. Yu D, Kuipers JG. Role of HLA-B27 in the pathogenesis of reactive arthritis. Rheum Dis Clin North Am 2003;29:21-36.
28. Kuipers JG, Zeidler H, Kohler L. How does Chlamydia cause arthritis? Rheum Dis Clin North Am 2003;29:613-29.
29. Stagg AJ, Hughes RA, Keat AC, et al. Antigen-presenting cells but not lymphocytes in the joint may indicate the cause of reactive arthritis. Br J Rheumatol 1996;35:1082-90.
30. El-Gabalawy HS, Lipsky PE. Reactive arthritis: etiology and pathogenesis. In: Hochberg MC, Silman AJ, Smolen JS, et al. Rheumatology. 3rd ed. Chicago: Mosby.
31. Ramos M, Lopez de Castro JA. HLA-B27 and the pathogenesis of spondyloarthritis. Tissue Antigens 2002;60:191-205.
32. Fiorillo MT, Maragno M, Butler, et al. CD8 (+) T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J Clin Invest 2000;106:47-53.
33. Kim TH, Uhm WS, Inman RD. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 2005;17:400-5.
34. Luthra-Guptasarma M, Singh B. HLA-B27 lacking associated beta2-microglobulin rearranges to auto-display or cross-display residues 169-181: a novel molecular mechanism for spondyloarthropathies. FEBS Lett 2004;24:1-8.
35. Keat A. Sexually transmitted arthritis syndromes. Med Clin North Am 1990;74:1617-30.
36. Norton WL, Lewis D, Ziff M. Light and electron microscopic observations on the synovitis of Reiter's disease. Arthritis Rheum 1966;9:747-57.
37. Weinberger WH, Ropes MW, Kulka JP, et al. Reiter's syndrome clinical and pathological observations: a long term study of 16 cases. Medicine (Baltimore) 1962;41:35-91.
38. Oates JK, Young AC. Sacroiliitis in Reiter's disease. BMJ 1959;i:1103-5.
39. Popert AJ, Gill AJ, Laird SM. A prospective study of Reiter's syndrome: an interim report on the first 82 cases. Br J Vener Dis 1964;40:160-5.
40. Fox R, Calin A, Gerber R, et al. The chronicity of symptoms and disability in Reiter's syndrome. Ann Intern Med 1979;91:190-3.
41. McGonagle D, Benjamin M, Marzo-Ortega H, et al. Advances in the understanding of entheseal inflammation. Curr Rheumatol Rep 2002;4:500-6.
42. Keat A. Sexually transmitted arthritis syndromes. Med Clin North Am 1990;74:1617-31.
43. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med 1983;309:1606-15.
44. Weathers DR, Baker G, Archard HO, et al. Psoriasiform lesions of the oral mucosa (with emphasis on "ectopic geographic tongue") Oral Surg Oral Med Oral Pathol 1974;37:872-88.
45. Griffiths HJ, Sundaram M. Pyoderma gangrenosum and erosive peripheral arthritis. Can Assoc Radiol J 1986;37:125-7.
46. Toivanen A. Reactive arthritis: clinical features and treatment. In: Hochberg MC, Silman AJ, Smolen JS, et al. Rheumatology. 3rd ed. Chicago: Mosby.
47. Hughes RA, Hyder E, Treharne JD, et al. Intra-articular chlamydial antigen and inflammatory arthritis. Q J Med 1991;80:575-88.
48. Csonka GW. The course of Reiter's syndrome. BMJ 1958;i:1088-90.
49. Konttinen YT, et al. IgA nephropathy in reactive arthritis. J Rheumatol 1987;14:1070-1.
50. Mielants H, Veys EM, De Vos M, et al. The evolution of spondylarthropathies in relation to gut histology, clinical aspects. J Rheumatol 1995;22:2266-72.
51. Mielants H, Veys EM, Cuvelier C, et al. The evolution of spondylarthropathies in relation to gut histology, histological aspects. J Rheumatol 1995;22:2273-8.
52. Bjarnason I, Helgason KO, Geirsson AJ, et al. Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis. Gastroenterology 2003;125:1598-605.
53. Hannu T, Nieminen MS, Swan H, et al. Cardiac findings of reactive arthritis: an observational echocardiographic study. Rheumatol Int 2002;21:169-72.
54. Angulo J, Espinoza LR. The spectrum of skin, mucosa and other extra-articular manifestations. Baillieres Clin Rheumatol 1998;12:649-64.
55. Sairanan E, Paronen I, Mahonen H. Reiters syndrome: a follow-up study. Acta Med Scand 1969;185:57-63.
56. Amor B, Santos RS, Nahal R, et al. Predictive factors for the long term outcome of spondylarthropathies. J Rheumatol 1994;21:1883-7.
57. van de Heijde D, Landewe R. Imaging in spondylitis. Curr Opin Rheumatol 2005;17:413-17.
58. Balint PV, Kane D, Wilson H, et al. Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy. Ann Rheum Dis 2002;61:905-10.
59. Zeidler H, Kuipers J, Kohler L. Chlamydia-induced arthritis. Current Opin Rheumatol 2004;16:380-92.
60. Carlin EM, Keat AC. European guideline for the management of sexually acquired reactive arthritis. Int J STD AIDS 2001;12(suppl 3):94-102.
61. Levy B. Arthritis in venereal disease, with particular reference to aetiology. Med J Malaya 1959;5:42-58.
62. Bardin T, Enel C, Cornelis F, et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992;35:190-4.
63. Short CL. Arthritis in the Mediterranean theater of operations. III: Clinical description of infectious and other types of arthritis. N Engl J Med 1947;236:468-73.
64. Fryden A, Bengtsson A, Foberg U, et al. Early antibiotic treatment of reactive arthritis associated with enteric infections: clinical and seroiogicai study. BMJ 1990;301:1299-302.
65. Locht H, Kihlstrom E, Lindstrom FD. Reactive arthritis after Salmonella among medical doctors-study of an outbreak. J Rheumatol 1993;20:845-8.
66. Lauhio A, Leirisalo-Repo M, Lahdevirta J, et al. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991;34:6-14.
67. Carter JD, Valeriano J, Vasey FB. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. J Rheumatol 2004;31:1973-80.
68. Toivanen A, Yli-Kerttula T, Luukkainen R, et al. Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993;11:301-7.
69. Sieper J, Fendler C, Laitko S, et al. No benefit of long-term ciprofloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis. Arthritis Rheum 1999;42:1386-96.
70. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, et al. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 2000;59:565-70.
71. Wakefield D, McCluskey P, Verma M, et al. Ciprofloxacin treatment does not influence course or relapse rate of reactive arthritis and anterior uveitis Arthritis Rheum 1999;42:1894-7.
72. Kvien TK, Gaston JSH, Bardin T, et al. Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis 2004;63:1113-19.
73. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, et al. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis 2003;62:880-4.
74. Nordstrom D, Lindy O, Lauhio A, et al. Anti-collagenolytic mechanism of action of doxycycline treatment in rheumatoid arthritis. Rheumatol Int 1998;17:175-80.
75. National Institute for Clinical Excellence Guidance on the use of cyclooxygenase (COX) 2 selective inhibitors, celecoxib, rofecoxib, meloxicam and etodolac for osteoarthritis and rheumatoid arthritis. London: NICE, 2001
76. National Institute for Clinical Excellence. Withdrawal of rofecoxib, 2004.
77. Melian A, van der Heijde D, James MK, et al.: Etoricoxib in the treatment of ankylosing spondylitis (AS), Arthritis Rheum, 2002;46:S432.
78. Clegg DO, Reda DJ, Weisman MH, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs cooperative study. Arthritis Rheum 1996;39:2021-7.
79. Charlotte E, Hansen TM, Andersen LS, et al. Limited effect of sulphasalazine treatment in reactive arthritis. A randomised double blind placebo controlled trial. Ann Rheum Dis 1997;56:32-6.
80. Anandarajah A, Ritchlin CT. Treatment update on spondyloarthropathy. Curr Opin Rheumatol 2005;17:247-56.
81. Oili KS, Niinisalo H, Korpilahde T, et al. Treatment of reactive arthritis with Infliximab. Scand J Rheumatol 2003;32:122-4.
82. Meador R, Hsia E, Kitumnuaypong T, et al. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis. Clin Exp Rheumatol 2002;20(suppl 28):S130-4.
83. Mody GM, Parke FA, Reveille JD. Articular manifestations of human immunodeficiency virus infection. Best Pract Res Clin Rheumatol 2003;17:265-87.
84. Reveille JD, Conant MA, Duvic M. HIV associated psoriasis, psoriatic arthritis and Reiter's syndrome. A disease continuum? Arthritis Rheum 1990;33:1574-8.
85. Davis P, Stein M, Latif A, et al. Acute arthritis in Zimbabwean patients: possible relationship to human immunodeficiency virus infection. J Rheumatol 1989;16:346-8.
86. Njobvu P, McGill P, Kerr H, et al. Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998;25:1553-9.
87. Stein CM, Davis P. Arthritis associated with HIV infection in Zimbabwe. J Rheumatol 1996;23:506-11.
88. Youssef PP, Bertouch JV, Jones PD. Successful treatment of human immunodeficiency virus-associated Reiter's syndrome with sulfasalazine. Arthritis Rheum 1992;35:723-4.